Form 8-K - Current report:
SEC Accession No. 0001140361-25-025295
Filing Date
2025-07-09
Accepted
2025-07-09 07:55:45
Documents
17
Period of Report
2025-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20051584_8k.htm   iXBRL 8-K 39175
2 EXHIBIT 4.1 ef20051584_ex4-1.htm EX-4.1 48589
3 EXHIBIT 10.1 ef20051584_ex10-1.htm EX-10.1 106616
4 EXHIBIT 10.2 ef20051584_ex10-2.htm EX-10.2 11045
5 EXHIBIT 99.1 ef20051584_ex99-1.htm EX-99.1 13459
9 image00001.jpg GRAPHIC 426608
  Complete submission text file 0001140361-25-025295.txt   980013

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20250708.xsd EX-101.SCH 3901
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20250708_lab.xml EX-101.LAB 21966
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20250708_pre.xml EX-101.PRE 16068
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20051584_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 251112292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)